ARTS II: Arterial Revascularization Therapies Study Part II of the Sirolimus-Eluting Bx VELOCITY Balloon Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions.
Latest Information Update: 18 May 2009
At a glance
- Drugs Sirolimus (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms ARTS-II
- Sponsors Cordis Corporation
- 12 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 May 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 24 Mar 2009 Planned end date changed from 1 Feb 2009 to 1 Mar 2009 as reported by ClinicalTrials.gov.